SEC Form 4 · accession 0001140361-17-008570
VASCULAR SOLUTIONS INC · VASC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Hennen
Officer — Sr. VP of Finance and CFO
Period of report
Feb 17, 2017
Accepted (ET)
Feb 22, 2017 · 4:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001030206
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Feb 17, 2017 | D | 30,444 | — | D | 0 | D | |
| Common StockF1 | holding | — | — | — | 30,444 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Increase in shares from last filing represents 33 shares acquired under the Vascular Solutions Employee Stock Purchase Plan for the period ending February 16, 2017 at $29.62/share.
- F2In connection with the merger of Issuer and a subsidiary of Teleflex Incorporated (the "Merger") pursuant to an agreement and plan of merger dated December 1, 2016, all shares of Issuer common stock were canceled and automatically converted into the right to receive $56.00 per share in cash, without interest and less any applicable withholding taxes.